Higher specialty training in trauma and orthopaedic surgery in Ireland is a six-year RCSI programme (ST3-ST8) treating traumatic, developmental and degenerative musculoskeletal conditions and related bone and soft-tissue tumours. Progression is tracked through biannual assessments on the Intercollegiate Surgical Curriculum Programme, and the FRCS exit exam is required for the Certificate of Completion of Surgical Training.
Work and interests
Trauma and orthopaedics combines acute injury care with treatment of developmental and degenerative musculoskeletal disease. It suits an interest in mechanics and practical problem solving, with patients ranging from children and athletes to older people with fragility fractures or painful joints.
Entry and selection for 2027
Entry is through direct progression from CST2 or ESR after completed CST or recognised equivalent training and the MRCS. ESR requires at least 12 months full-time equivalent experience in a standalone post in the chosen specialty, with logbooks, trainer reports, qualification evidence and any required operative-skills/human-factors assessments. Medical Council and English-language eligibility also apply.
For 2027, direct Pathway scoring is CST500 (CAPA/logbook/OSCEs 425 and weighted MRCS PartB75), academic 40 and interview 460, totalling 1000. The five interview weights are 100,40,100,120 and 100 for quality/safety, academic development, current surgical issues, decision making, and professionalism/probity respectively. T&O has its own academic matrix: thesis 15, other degrees 10, publications 15, presentations 10 and prizes 5 are capped at 20 raw marks together; courses add up to 5 before scaling the 25-mark raw score to 40.
ESR uses a separate model: qualifying CST/equivalence earns 0 marks; post-CST clinical experience is assessed out of 45 and academic achievement out of 55, with the combined score rescaled to 600. The five interview stations carry 80 marks each (400 total). Do not add the Pathway and ESR scorecards together.
Both routes require at least 60% pre-interview and 60% overall interview, plus a mandatory 60% pass in decision-making station 4. Passing the aggregate cannot compensate for failing that station. For ESR, reaching 60% does not guarantee an interview; a 3:1 applicant-to-post shortlist may be used.
Applying
July 2027: direct Pathway applications 15 October–13 November 2026. ESR applications opened 14 October 2026 at 12 noon and closed 13 November 2026 at 12 noon (RCSI now lists the 2027 intake as closed); submit the required hard copy. Eligible academic and final-six-month clinical evidence updates are accepted to 8 January 2027. The intake guide gives interviews in the week beginning 15 March 2027. The T&O ESR application form leaves the interview date subject to confirmation; RCSI’s separate non-RCSI ESR form lists Thursday 18 March 2027 for T&O, also subject to confirmation. Confirm your individual invitation.